SCHEMBL9327404

SCHEMBL9327404

CCCCC(=O)OC(=O)C(CCC)Oc1ccc(C(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
PLA2G4B P0C869 7/20 0.45
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
RARB P10826 4/20 0.43
PPARG P37231 2/20 0.42
PPARA Q07869 2/20 0.42
PLA2G4A P47712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9328682 0.90 TP53 (0.50) HTTTP53TSHRPLA2G4BKMT2A
SCHEMBL9327394 0.88 KMT2A (0.53) HTTTP53TSHRPLA2G4BKMT2A
SCHEMBL9328675 0.83 TP53 (0.56) HTTTP53TSHRPLA2G4BKMT2A
SCHEMBL9327414 0.81 KMT2A (0.51) HTTTP53TSHRPLA2G4BKMT2A
SCHEMBL2230124 0.79 PPARG (0.63) TP53TSHRPLA2G4BKMT2APPARG
SCHEMBL11577658 0.78 CTRC (0.47) KMT2APPARGPPARA
SCHEMBL11617523 0.78 CTRC (0.47) KMT2APPARGPPARA
SCHEMBL10335506 0.78 KDM4E (0.64) HTTTP53TSHRKMT2AL3MBTL1
SCHEMBL2233261 0.76 TP53 (0.54) TP53TSHRPLA2G4BKMT2ARARB
SCHEMBL9329257 0.76 TP53 (0.55) HTTTP53TSHRPLA2G4BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637405-B2 Integrated process for generating acid anhydrides CLEANTECH BUILDING MATERIALS PLC (GB) 2026-05-26 US disclosed
US-20250304521-A1 PROCESS FOR GENERATING ACID ANHYDRIDES CLEANTECH BUILDING MATERIALS PLC (GB) 2025-10-02 US disclosed
US-12358860-B2 Process for generating acid anhydrides CLEANTECH BUILDING MATERIALS PLC (GB) 2025-07-15 US disclosed
CN-115551800-B Method for producing acid anhydrides 纮康公司 2025-04-01 CN disclosed
WO-2024097923-A1 INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDES HYCONIX, INC. (US) 2024-05-10 WO disclosed
EP-4334280-A1 INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDES Hyconix, Inc. (US) 2024-03-13 EP disclosed
CN-117677602-A Integrated process for producing anhydrides 纮康公司 2024-03-08 CN disclosed
US-20230120038-A1 PROCESS FOR GENERATING ACID ANHYDRIDES HYCONIX, INC. (US) 2023-04-20 US disclosed
US-11608306-B2 Process for generating acid anhydrides HYCONIX, INC. (US) 2023-03-21 US disclosed
EP-4146590-A1 PROCESS FOR GENERATING ACID ANHYDRIDES Hyconix, Inc. (US) 2023-03-15 EP disclosed
CN-115551800-A Process for producing acid anhydride 纮康公司 2022-12-30 CN disclosed
US-20220371983-A1 INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDES HYCONIX, INC. (US) 2022-11-24 US disclosed
US-20210347722-A1 PROCESS FOR GENERATING ACID ANHYDRIDES HYCONIX, INC. (US) 2021-11-11 US disclosed
WO-2021226433-A1 PROCESS FOR GENERATING ACID ANHYDRIDES HYCONIX, INC. (US) 2021-11-11 WO disclosed
EP-0368912-B1 POLYANHYDRIDES WITH IMPROVED HYDROLYTIC DEGRADATION PROPERTIES MASSACHUSETTS INST TECHNOLOGY (US) 1994-03-16 EP disclosed
EP-0368912-A4 POLYANHYDRIDES WITH IMPROVED HYDROLYTIC DEGRADATION PROPERTIES 1990-12-19 EP disclosed
EP-0368912-A1 POLYANHYDRIDES WITH IMPROVED HYDROLYTIC DEGRADATION PROPERTIES. MASSACHUSETTS INST TECHNOLOGY (US) 1990-05-23 EP disclosed
US-4857311-A FROM P-CARBOXYPHEN(-OXY OR -YL)ALKANOIC ACID; BIODEGRADABLE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-08-15 US disclosed
WO-1989000855-A1 POLYANHYDRIDES WITH IMPROVED HYDROLYTIC DEGRADATION PROPERTIES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11608306-B2 Process for generating acid anhydrides CA1, CA9, CA6 HTT 3063/4885TP53 2589/4885TSHR 4610/4885
US-20210347722-A1 PROCESS FOR GENERATING ACID ANHYDRIDES CA1, CA9, CA6 HTT 3063/4885TP53 2589/4885TSHR 4610/4885
US-20220371983-A1 INTEGRATED PROCESS FOR GENERATING ACID ANHYDRIDES CA3, CA9, CA4 HTT 3345/4885TP53 2929/4885TSHR 3581/4885
US-20250304521-A1 PROCESS FOR GENERATING ACID ANHYDRIDES CA1, CA9, CA6 HTT 3063/4885TP53 2589/4885TSHR 4610/4885
US-20230120038-A1 PROCESS FOR GENERATING ACID ANHYDRIDES CA1, CA9, CA6 HTT 3063/4885TP53 2589/4885TSHR 4610/4885
US-12358860-B2 Process for generating acid anhydrides CA1, CA9, CA6 HTT 3063/4885TP53 2589/4885TSHR 4610/4885
US-12637405-B2 Integrated process for generating acid anhydrides GRHPR, GCDH, OGDH HTT 3208/4885TP53 2024/4885TSHR 3123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.